Intelligent Diabetes Management System with Enhanced Pharmaceutical Compositions
Legal Citation
Summary of the Inventive Concept
A synergistic system integrating advanced technologies with optimized pharmaceutical compositions for personalized diabetes management and treatment.
Background and Problem Solved
The original patent relates to a pharmaceutical composition comprising Canagliflozin, but it has limitations in terms of personalized treatment and real-time monitoring. The new inventive concept addresses these limitations by incorporating blockchain, IoT, AI, and biodegradable materials to create a more powerful and effective system.
Detailed Description of the Inventive Concept
The new inventive concept comprises a wearable device integrated with a blockchain-based data storage system, which collects and analyzes physiological data to provide personalized treatment recommendations based on the optimized pharmaceutical composition. The system also includes an AI-powered formulation optimization module, IoT-enabled sensors for real-time stability monitoring, and a 3D printing process for manufacturing pharmaceutical compositions with controlled release properties. Additionally, the system incorporates machine learning algorithms to predict pharmaceutical composition efficacy and a notification system for alerting users of any changes in composition stability.
Novelty and Inventive Step
The new inventive concept combines distinct technologies to create a novel system that is not obvious from the original patent. The integration of blockchain, IoT, AI, and biodegradable materials with optimized pharmaceutical compositions provides a unique solution for personalized diabetes management and treatment.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT sensors, or biodegradable materials. Variations of the system could also include integration with other healthcare systems, such as electronic health records or telemedicine platforms.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the diabetes management and treatment market, with potential applications in personalized medicine, real-time monitoring, and pharmaceutical composition optimization. The target industries include pharmaceutical companies, healthcare providers, and medical device manufacturers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation and drug delivery systems, with expertise in diabetes medication technologies, pharmaceutical composition design, and advanced drug delivery mechanisms
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degree in pharmaceutical sciences, experience in drug formulation, knowledge of controlled release technologies, familiarity with emerging medical device and data integration technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD represents a predictable extension of the source patent's pharmaceutical composition teachings by integrating known technologies for monitoring, optimizing, and personalizing drug delivery. The combination of blockchain, AI, and IoT sensors with the existing Canagliflozin formulation represents an incremental technological advancement using standard engineering techniques for pharmaceutical innovation.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,559 |
|---|---|
| Title | Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof |
| Assignee(s) | Aurobindo Pharma Ltd |